News
HM administrators plan for 2021 and beyond
August 13, 2021
“If there was ever doubt that the hospitalists are the beating heart of the hospital, this doubt is now gone,” said Elda Dede, FHM.
News
FDA authorizes booster shot for immunocompromised Americans
August 13, 2021
Those eligible for a third dose include solid organ transplant recipients, those undergoing cancer treatments, and people with autoimmune diseases that suppress their immune systems.
News
Hospitals struggle to find nurses, beds, even oxygen as Delta surges
August 12, 2021
“We have a vaccine, which is the key to ending this pandemic and people just refuse to take it, and so I think we’re very frustrated.”
News
FDA may okay COVID booster for vulnerable adults before weekend: Media
August 12, 2021
Between one-third and one-half of immunocompromised patients who didn’t develop detectable levels of virus-fighting antibodies after two doses of a COVID vaccine will respond to a third dose.
News
COVID-19 mitigation measures led to shifts in typical annual respiratory virus patterns
August 11, 2021
“Clinicians should be aware of increases in some respiratory virus activity and remain vigilant for off-season increases.”
News
Myocarditis in adolescents after COVID-19 vaccine typically mild
August 11, 2021
“Despite the risks of myocarditis associated with vaccination, the benefits of vaccination likely outweigh risks in children and adolescents.”
News
Surge of new child COVID cases continues for 6th consecutive week
August 10, 2021
Upward trend in vaccine initiation is now in its 4th week among 12- to 15-year-olds.
Opinion
Microlearning during the pandemic
August 9, 2021
Microlearning occurs when clinicians turn to their smartphones or tablets in order to discover something, answer a question, or complete a task.
News
Fauci says ‘unprecedented’ conditions could influence COVID vaccine approval for kids
August 6, 2021
“If I were a [non-COVID] virus looking for a niche, I would be really confused,” Dr. Fauci told pediatric hospitalists.
News
Injectable monoclonal antibodies prevent COVID-19 in trial
August 6, 2021
The cocktail of casirivimab and imdevimab reduced the relative risk of infection by 72% in patients at high risk of infection.